Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Key Highlights
Regeneron Pharmaceuticals, Inc. (Regeneron or 'the company') discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The company offer drugs for patients with cancer, eye diseases, cardiovascular and metabolic diseases, allergic and inflammatory diseases, infectious diseases, neuromuscular diseases, rare diseases and asthma. Its major drugs include Dupixent injection, Eylea injection, Arcalyst injection, Praluent injection, Libtayo Injection, Zaltrapinjection and Kevzara injection. Regeneron sells its products to various distributors and specialty pharmacies in the US. It has business operations in in Limerick, Ireland and Rensselaer, New York, the US. The company is headquartered in Tarrytown, New York, the US.Scope
- Detailed information on Regeneron Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Regeneron Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Regeneron Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Regeneron Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Regeneron Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Regeneron Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Regeneron Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Regeneron Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Regeneron Pharmaceuticals, Inc.: Company Overview
- Regeneron Pharmaceuticals, Inc.: Overview and Key Facts
- Regeneron Pharmaceuticals, Inc.: Overview
- Regeneron Pharmaceuticals, Inc.: Key Facts
- Regeneron Pharmaceuticals, Inc.: Key Employees
- Regeneron Pharmaceuticals, Inc.: Key Employee Biographies
- Regeneron Pharmaceuticals, Inc.: Major Products and Services
- Regeneron Pharmaceuticals, Inc.: Company History
- Regeneron Pharmaceuticals, Inc.: Management Statement
- Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries
- Regeneron Pharmaceuticals, Inc.: Key Competitors
- Regeneron Pharmaceuticals, Inc.: Company Analysis
- Regeneron Pharmaceuticals, Inc.: Business Description
- Regeneron Pharmaceuticals, Inc.: SWOT Analysis
- Regeneron Pharmaceuticals, Inc.: SWOT Overview
- Regeneron Pharmaceuticals, Inc.: Strengths
- Regeneron Pharmaceuticals, Inc.: Weaknesses
- Regeneron Pharmaceuticals, Inc.: Opportunities
- Regeneron Pharmaceuticals, Inc.: Threats
- Regeneron Pharmaceuticals, Inc.: Corporate Financial Deals Activity
- Regeneron Pharmaceuticals, Inc.: Financial Deals Overview
- Regeneron Pharmaceuticals, Inc.: Targets and Partners
- Regeneron Pharmaceuticals, Inc.: Top Deals 2018 - 2022YTD*
- Regeneron Pharmaceuticals, Inc.: Advisors
- Regeneron Pharmaceuticals, Inc.: Top Legal Advisors
- Regeneron Pharmaceuticals, Inc.: Top Financial Advisors
- Regeneron Pharmaceuticals, Inc.: Mergers and Acquisitions
- Regeneron Pharmaceuticals, Inc.: Corporate Venturing
- Regeneron Pharmaceuticals, Inc.: Capital Raising
- Regeneron Pharmaceuticals, Inc.: Partnership
- Regeneron Pharmaceuticals, Inc.: Recent Developments
- Regeneron Pharmaceuticals, Inc.: News and Events Summary
- Regeneron Pharmaceuticals, Inc.: Financial Deals
- Regeneron Pharmaceuticals, Inc.: Financial Performance
- Regeneron Pharmaceuticals, Inc.: Market Developments
- Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events
- Regeneron Pharmaceuticals, Inc.: Research & Development
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
Table 1: Regeneron Pharmaceuticals, Inc.: Key Facts
Table 2: Regeneron Pharmaceuticals, Inc.: Key Employees
Table 3: Regeneron Pharmaceuticals, Inc.: Company History
Table 4: Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Regeneron Pharmaceuticals, Inc.: Key Competitors
Table 6: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Table 8: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: Regeneron Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 10: Regeneron Pharmaceuticals, Inc.: Targets and Partners
Table 11: Regeneron Pharmaceuticals, Inc.: Top Deals 2018 - 2022YTD*
Table 12: Regeneron Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 13: Regeneron Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 14: Regeneron Pharmaceuticals, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Table 16: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 17: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Table 18: Regeneron Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 19: Regeneron Pharmaceuticals, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 20: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 21: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 22: Regeneron Pharmaceuticals, Inc.: News and Events Summary
Table 23: Regeneron Pharmaceuticals, Inc.: Financial Deals
Table 24: Regeneron Pharmaceuticals, Inc.: Financial Performance
Table 25: Regeneron Pharmaceuticals, Inc.: Market Developments
Table 26: Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 27: Regeneron Pharmaceuticals, Inc.: Research & Development
List of Figures
Figure 1: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: Regeneron Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Regeneron Pharmaceuticals, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: Regeneron Pharmaceuticals, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 8: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 9: Regeneron Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 10: Regeneron Pharmaceuticals, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 11: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 12: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
